These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 11920632

  • 1. Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma.
    Lo KW, Tsang YS, Kwong J, To KF, Teo PM, Huang DP.
    Int J Cancer; 2002 Apr 10; 98(5):651-5. PubMed ID: 11920632
    [Abstract] [Full Text] [Related]

  • 2. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB, Lo KW, Kwong J, Lam EC, Chan SY, Chow LS, Chan AS, Teo PM, Huang DP.
    Mol Carcinog; 2003 Dec 10; 38(4):170-8. PubMed ID: 14639656
    [Abstract] [Full Text] [Related]

  • 3. The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells.
    Pao MM, Tsutsumi M, Liang G, Uzvolgyi E, Gonzales FA, Jones PA.
    Hum Mol Genet; 2001 Apr 15; 10(9):903-10. PubMed ID: 11309363
    [Abstract] [Full Text] [Related]

  • 4. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.
    Zhao BJ, Sun DG, Zhang M, Tan SN, Ma X.
    Dis Esophagus; 2009 Apr 15; 22(1):55-61. PubMed ID: 18564167
    [Abstract] [Full Text] [Related]

  • 5. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.
    Kwong J, Lo KW, Chow LS, Chan FL, To KF, Huang DP.
    Int J Cancer; 2005 Jan 20; 113(3):386-92. PubMed ID: 15455391
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic and genetic alterations of the EDNRB gene in nasopharyngeal carcinoma.
    Zhou L, Feng X, Shan W, Zhou W, Liu W, Wang L, Zhu B, Yi H, Yao K, Ren C.
    Oncology; 2007 Jan 20; 72(5-6):357-63. PubMed ID: 18187958
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Promoter hypermethylation of high-in-normal 1 gene in primary nasopharyngeal carcinoma.
    Wong TS, Kwong DL, Sham JS, Tsao SW, Wei WI, Kwong YL, Yuen AP.
    Clin Cancer Res; 2003 Aug 01; 9(8):3042-6. PubMed ID: 12912954
    [Abstract] [Full Text] [Related]

  • 11. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.
    Chow LS, Lo KW, Kwong J, Wong AY, Huang DP.
    Oncol Rep; 2004 Oct 01; 12(4):781-7. PubMed ID: 15375500
    [Abstract] [Full Text] [Related]

  • 12. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST, Tsao SW, Tao Q.
    Oncogene; 2004 Jun 10; 23(27):4793-806. PubMed ID: 15122337
    [Abstract] [Full Text] [Related]

  • 13. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
    Kwong J, Lo KW, To KF, Teo PM, Johnson PJ, Huang DP.
    Clin Cancer Res; 2002 Jan 10; 8(1):131-7. PubMed ID: 11801549
    [Abstract] [Full Text] [Related]

  • 14. Frequent epigenetic inactivation of Myocardin in human nasopharyngeal carcinoma.
    Chen F, Mo Y, Ding H, Xiao X, Wang SY, Huang G, Zhang Z, Wang SZ.
    Head Neck; 2011 Jan 10; 33(1):54-9. PubMed ID: 20848417
    [Abstract] [Full Text] [Related]

  • 15. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma.
    Jerónimo C, Henrique R, Campos PF, Oliveira J, Caballero OL, Lopes C, Sidransky D.
    J Clin Pathol; 2003 Jan 10; 56(1):52-5. PubMed ID: 12499435
    [Abstract] [Full Text] [Related]

  • 16. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH, Huang LC, Hsu YH.
    Anticancer Res; 2002 Jan 10; 22(6C):4109-13. PubMed ID: 12553040
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Aberrant promoter hypermethylation of CHFR in nasopharyngeal carcinoma].
    Huang T, Du C, Yu N, Xiao X, Zhou X, Wang S, Huang G, Zhang Z.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Aug 10; 25(16):746-50. PubMed ID: 22070084
    [Abstract] [Full Text] [Related]

  • 19. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
    Zhang Z, Sun D, Van do N, Tang A, Hu L, Huang G.
    Int J Cancer; 2007 Jan 01; 120(1):32-8. PubMed ID: 17013896
    [Abstract] [Full Text] [Related]

  • 20. Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma.
    Wang T, Liu H, Chen Y, Liu W, Yu J, Wu G.
    J Exp Clin Cancer Res; 2009 Dec 30; 28(1):160. PubMed ID: 20042089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.